Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV Infection

Journal of Medical Virology

Volumn 81, Issue 5, 2009, Pages 888-896

  Simonelli, C ^a   Tedeschi, R ^a   Gloghini, A ^a   Talamini, R ^a   Bortolin, M T ^a   Berretta, M ^a   Spina, M ^a   Morassut, S ^a   Vaccher, E ^a   De Paoli, P ^a   Carbone, A ^b   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

HHV 8; HIV infection; Multicentric Castleman Disease; Primary effusion lymphoma; Viral load

Indexed keywords

ALBUMIN; ANTHRACYCLINE; ANTIRETROVIRUS AGENT; BLEOMYCIN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HEMOGLOBIN; LACTATE DEHYDROGENASE; PREDNISONE; VINCA ALKALOID;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENERAL CONDITION; HEMATOLOGICAL PARAMETERS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHODGKIN LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; PROGNOSIS; SOLID LYMPHOMA; SURVIVAL TIME; THROMBOCYTE; VIRUS LOAD; VIRUS PATHOGENESIS; WELLBEING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; LYMPHOMA; LYMPHOMA, AIDS-RELATED; LYMPHOMA, PRIMARY EFFUSION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

HUMAN HERPESVIRUS 8; VINCA;

EID: 65649129288     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21349     Document Type: Article

References (39)

1. Aaron L, Lidove O, Yousry C, Roudiere L, Dupont B, Viard JP. 2002. Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: The impact of highly active antiretroviral therapy. Clin Infect Dis 35:880.
2. Ancelle-Park R. 1993. Expanded European AIDS case definition. Lancet 341:441.
3. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Sc. Publication. 1987.
4. Boivin G, Gaudreau A, Routy JP. 2000. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. AIDS 14:1907.
5. Bortolin MT, Pratesi C, Dolcetti R, Bidoli E, Vaccher E, Zanussi S, Tedeschi R, De Paoli P. 2006. Clinical value of Epstein-Barr virus DNA levels in peripheral blood samples of Italian patients with Undifferentiated Carcinoma of Nasopharyngeal Type. Cancer Lett 233:247.
6. Boulanger E, Daniel MT, Agbalika F, Oksenhendler E. 2003. Combined chemotherapy including high-dose methotrexate in KSHV/HHV-8-associated primary effusion lymphoma. Am J Hematol 73:143.
7. Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF, Cadranel J, Chevret S, Oksenhendler E. 2005. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23:4372.
8. Campbell TB, Borok M, Gwanzura L. 1999. HHV-8 peripheral blood viral load and the titer of antibodies against HHV-8. N Engl J Med 341:1241.
9. CarboneA,GaidanoG.1997.HHV-8positivebodycavity-basedlymphoma: Anovellymphomaentity.BrJHaematol97:515.(Pubitemid27240559)
10. Carbone A, Gloghini A, Vaccher E, Zagonel V, Pastore C, Dalla Palma P, Branz F, Saglio G, Volpe R, Tirelli U, Gaidano G. 1996. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 94:533.
11. Carbone A, Gloghini A, Vaccher E, Cerri M, Gaidano G, Dalla-Favera R, Tirelli U. 2005. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas. A tissue-based variant of primary effusion lymphoma. J Mol Diagn 7:17.
12. Castleman B, Iverson L, Menendez VP. 1956. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9:822.
13. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Engl J Med 332:1186.
14. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865.
15. Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, Parravicini C. 2001. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98:3473.
16. Cox DR. 1972. Regression models and life tables. J Roy Stat Soc B 34:187.
17. de Jong RB, Kluin PM, Rosati S, van Haelst PL, Sprenger HG, van Spronsen DJ. 2003. Sustained high levels of serum HHV-8 DNA years before multicentric Castleman's disease despite full suppression of HIV with highly active antiretroviral therapy. AIDS 17:1407.
18. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG. 2001. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97:2130.
19. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C. 2000. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-posivite plasmablastic lymphoma. Blood 95:1406.
20. Engels EA, Pittaluga S, Whitby D, Rabkin C, Aoki Y, Jaffe ES, Goedert JJ. 2003. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: A role for Kaposi's sarcoma-associated herpesvirus. Mod Pathol 16:424.
21. Grandadam M, Dupin N, Calvez V, Gorin I, Blum L, Kernbaum S, Sicard D, Buisson Y, Agut H, Escande JP, Huraux JM. 1997. Exacerbation of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis 175:1198.
22. Kaplan E, Meier P. 1958. Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:29-41.
23. Keller AR, Hochholzer L, Castleman B. 1972. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670.
24. Marrache F, Larroche C, Memain N, Bouchaud O, Robineau M, Hermine O, Lortholary O. 2003. Prolonged remission of HIV-associated multicentric Castleman's disease with an anti-CD20 monoclonal antibody as primary therapy. AIDS 17:1409.
25. Morassut S, Vaccher E, Balestreri L, Gloghini A, Gaidano G, Volpe R, Tirelli U, Carbone A. 1997. HIV-associated HHV-8 positive primary lymphomatous effusions: Radiological findings in six patients. Radiology 205:459.
26. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM. 1996. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88:645.
27. Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, Cazals-Hatem D, Autran B, Clauvel JP, Raphael M. 1996. Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 patients. AIDS 10:61.
28. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP, Agbalika F. 2000. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 96:2069. (Pubitemid 32098914)
29. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V. 2002. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99:2331.
30. Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, Stetler-Stevenson M, Jaffe ES, Raffeld M. 1996. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal malignancies. Leukemia 10:1358.
31. Scott D, Cabral L, Harrington W, Jr. 2001. Treatment of HIV-associated multicentric Castleman's disease with oral etoposide. Am J Hematol 66:148.
32. Simonelli C, Spina M, Cinelli R, Talamini R, Tedeschi R, Gloghini A, Vaccher E, Carbone A, Tirelli U. 2003. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single-institution study. J Clin Oncol 21:3948.
33. Simonelli C, Tedeschi R, Gloghini A, Bortolin MT, Spina M, Bidoli E, Cinelli R, De Paoli P, Carbone A, Tirelli U. 2005. Characterization of immunological and virological parameters in HIV patients with primary effusion lymphoma during antiblastic therapy and HAART. Clin Infect Dis 40:1022.
34. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276.
35. Spina M, Gaidano G, Carbone A, Capello D, Tirelli U. 1998. Highly active antiretroviral therapy in human herpesvirus-8-related body-cavity-based lymphoma. AIDS 12:955.
36. Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner J. 2001. Viral load human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 39:4269.
37. Tedeschi R, Dillner J, De Paoli P. 2002. Laboratory diagnosis of human herpesvirus 8 infection in humans. Eur J Clin Microbiol Infect Dis 21:831.
38. Wit FW, Sol CJ, Renwick N, Roos MT, Pals ST, van Leeuwen R, Goudsmit J, Reiss P. 1998. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy. AIDS 12:218.
39. Zietz C, Bogner JR, Goebel FD, Lohrs U. 1999. An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS. N Engl J Med 340:1923.